Colistin Monotherapy versus Colistin plus Sitafloxacin for Therapy of Carbapenem-Resistant Acinetobacter baumannii Infections: A Preliminary Study

The Role of Colistin in the Era of New β-Lactam/β-Lactamase Inhibitor Combinations

(2022) Abdullah Tarık Aslan et al.   Antibiotics-Basel

Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis

(2022) Chienhsiu Huang et al.   Journal of Clinical Medicine

Clinical Efficacy and Nephrotoxicity of Colistin Alone versus Colistin Plus Vancomycin in Critically Ill Patients Infected with Carbapenem-Resistant Acinetobacter baumannii: A Propensity Score-Matched Analysis

(2021) Wasan Katip et al.   Pharmaceutics

The effectiveness and nephrotoxicity of loading dose colistin combined with or without meropenem for the treatment of carbapenem-resistant A. baumannii

(2020) Wasan Katip et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

In Vitro Activities of Colistin and Sitafloxacin Combinations against Multidrug-, Carbapenem-, and Colistin-Resistant Acinetobacter baumannii Using the Broth Microdilution Checkerboard and Time-Kill Methods

(2020) Vipavee Rodjun et al.   Antibiotics-Basel

Pharmacokinetics and Penetration of Sitafloxacin into Alveolar Epithelial Lining Fluid in Critically Ill Thai Patients with Pneumonia

(2019) Taniya Paiboonvong et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

(2018) Mical Paul et al.   LANCET INFECTIOUS DISEASES

Acinetobacter spp. as nosocomial pathogens: Epidemiology and resistance features

(2018) Saad B. Almasaudi   SAUDI JOURNAL OF BIOLOGICAL SCIENCES

Preliminary Clinical Study of the Effect of Ascorbic Acid on Colistin-Associated Nephrotoxicity

(2015) Rujipas Sirijatuphat et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparative in vitro activity of sitafloxacin against bacteremic isolates of carbapenem resistant Acinetobacter baumannii complex

(2015) Yu-Shan Huang et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Preliminary Study of Colistin versus Colistin plus Fosfomycin for Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections

(2014) Rujipas Sirijatuphat et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial

(2013) Emanuele Durante-Mangoni et al.   CLINICAL INFECTIOUS DISEASES

In vitro activity of sitafloxacin against carbapenem-resistant Acinetobacter baumannii

(2013) Visanu Thamlikitkul et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Population pharmacokinetics and pharmacodynamics of sitafloxacin in patients with community-acquired respiratory tract infections

(2013) Yusuke Tanigawara et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

‘Old’ antibiotics for emerging multidrug-resistant bacteria

(2012) Phillip J. Bergen et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Sitafloxacin

(2011) Gillian M. Keating   DRUGS